FdaNdcDirectoryPulse / compare
BRYTLY vs OURUI ONE FUNGAL NAIL TREATMENT: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and OURUI ONE FUNGAL NAIL TREATMENT (2026-09-29) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to OURUI ONE FUNGAL NAIL TREATMENT?
| Field | BRYTLY | OURUI ONE FUNGAL NAIL TREATMENT |
|---|---|---|
| Product | BRYTLY | OURUI ONE FUNGAL NAIL TREATMENT |
| Generic name | Apraclonidine Hydrochloride | Undecylenic Acid 25% FUNGAL NAIL TREATMENT |
| NDC | 0065-8596 | 87786-074 |
| Labeler | Alcon Laboratories, Inc. | Wenzhou Yuyuan Pharmaceutical Co., Ltd. |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | OTC MONOGRAPH DRUG |
| Application number | NDA220341 | M005 |
| Dosage form | SOLUTION/ DROPS | LIQUID |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | UNDECYLENIC ACID 25 g/100mL |
| Marketing start | 2026-10-16 | 2026-09-29 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · OURUI ONE FUNGAL NAIL TREATMENT
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.